Clay Hurtubise - Comment
Posted : 10/27/2010     ID ：FDA-2010-N-0486-0002     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

William Kimball Vaughan - Comment
Posted : 10/27/2010     ID ：FDA-2010-N-0486-0003     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Joanne Locke - Comment
Posted : 10/27/2010     ID ：FDA-2010-N-0486-0004     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Pinney Associates - Comment
Posted : 10/27/2010     ID ：FDA-2010-N-0486-0005     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Safe Injection Practices Policy Task Force - Comment
Posted : 11/10/2010     ID ：FDA-2010-N-0486-0006     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Becton Dickinson (BD) - Comment
Posted : 11/10/2010     ID ：FDA-2010-N-0486-0007     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Mark R Basile - Comment
Posted : 11/10/2010     ID ：FDA-2010-N-0486-0008     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

Monique Sheppard - Comment
Posted : 12/21/2010     ID ：FDA-2010-N-0486-0009     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

National Family Partnership - Comment
Posted : 12/21/2010     ID ：FDA-2010-N-0486-0010     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET

The United States Pharmacopeial Convention (USP) - Comment
Posted : 02/10/2011     ID ：FDA-2010-N-0486-0011     Agency : FDA

Comment Period Closed
Jan 31,2011 11:59 PM ET